Calming and soothing efficacy of a skincare probiotic containing live bacteria Lactobacillus rhamnosus and berry seed oils on atopic dermatitis lesions.
Atopic dermatitis (AD) is a chronic inflammatory and pruritic skin disease characterized by a reduced diversity of microbiomes that favors colonization of the skin by pathogenic bacteria.
A novel approach to the treatment of these diseases is using specific beneficial probiotics aimed at restoring the balance of the skin microbiome and decreasing the colonization of pathogens.
Objective: This study evaluated the soothing efficacy and tolerability of a new probiotic-based skin care product combining two live strains and berry seed oils on eczematous lesions in subjects with atopic skin.
Adults with atopic skin and an inflammatory lesion applied the product to thin skin for 28 days, once or twice daily. Severity of eczema signs (EASI score) and intensity of pruritus (VAS) were assessed.
Skin tolerability and subject satisfaction were investigated. Results: Statistically significant decrease in mean EASI score after 28 days (−27%, p = 0.011). A visible improvement
A change in skin appearance was observed in 67% of subjects at week 4.
Pruritus intensity decreased by 57% on average compared to baseline (p = 0.011). This effect was seen in 86% of subjects. Conclusion: The results suggest that this skin care product containing two live strains of Lactobacillus rhamnosus and berry seed oils hastens recovery in the treatment of eczematous lesions in subjects with atopic skin.
Authors: Blessed Imko-Walczuk1, Aleksandra Taraszkiewicz1, Annika Mäyrä2
Photo by cottonbro.